Description
Semaglutide is a modified glucagon-like peptide-1 (GLP-1) analogue investigated through its activity at the GLP-1 receptor. The discovery programme examined how peptide modifications influence receptor activity, enzymatic stability and albumin interaction. This 10mg catalogue entry provides a research reference for the compound rather than describing a finished pharmaceutical formulation.
Mechanism & Research Background
Semaglutide’s structure includes modifications designed to resist enzymatic degradation and support albumin binding. These features form part of its published pharmacological profile. In receptor-focused research, semaglutide can be distinguished from tirzepatide, which has a dual GIP/GLP-1 profile, and retatrutide, which also targets the glucagon receptor.
Areas of Research
- GLP-1 receptor activity and peptide structure–activity relationships.
- Albumin interaction and stability-related peptide modifications.
- Comparative single- and multi-receptor signalling studies.
An assay using a research material is different from a study of a specific medicine or delivery system. Published findings do not establish that this catalogue product is equivalent to a branded medicine, and the supplied strength does not indicate a dosing schedule. Researchers should distinguish compound mass from solution concentration and record the material’s exact identity and analytical basis.
Product Details
- Product: Semaglutide 10mg
- Listed quantity: 10mg
- Compound class: GLP-1 receptor agonist peptide
- Product code: SM10
Storage & Handling
Follow the storage conditions and handling guidance in the applicable supplier documentation. Protect the material from unsuitable heat, light and moisture, and record the batch used in each experiment. Preparation and storage requirements depend on the supplied formulation and the research method.
Batch Documentation
Certificates of analysis should be matched to the product and batch. Consult the relevant report for measured identity, content and purity; a purity result alone does not establish sterility or endotoxin status.
Research References
Important Notice
Premium research peptides synthesised and shipped from Australia. For in-vitro research purposes only. Strictly not for human or veterinary consumption. All products supplied are strictly for laboratory research and development. This information describes the compound’s research background and does not provide dosing instructions or claim a therapeutic benefit.
Reviews
There are no reviews yet.